Comparison of platinum-based neoadjuvant chemotherapy and primary debulking surgery in patients with advanced ovarian cancer

Comparison of platinum-based neoadjuvant chemotherapy and primary debulking surgery in patients with advanced ovarian cancer


چاپ صفحه
پژوهان
صفحه نخست سامانه
چکیده مقاله
چکیده مقاله
نویسندگان
نویسندگان
دانلود مقاله
دانلود مقاله
دانشگاه علوم پزشکی تبریز
دانشگاه علوم پزشکی تبریز

نویسندگان: منیژه سیاح ملی , شهریار هاشم زاده , علی اصفهانی , الهه اولاد صاحب مدارک , مهری جعفری شبیری , پروین مصطفی قره باغی , رامین آژوغ

کلمات کلیدی: Ovarian cancer, Advanced stage, Neoadjuvant chemotherapy, Primary debulking surgery

نشریه: 0 , 6 , 63 , 2013

اطلاعات کلی مقاله
hide/show

نویسنده ثبت کننده مقاله منیژه سیاح ملی
مرحله جاری مقاله تایید نهایی
دانشکده/مرکز مربوطه سلامت باروری زنان
کد مقاله 71647
عنوان فارسی مقاله Comparison of platinum-based neoadjuvant chemotherapy and primary debulking surgery in patients with advanced ovarian cancer
عنوان لاتین مقاله Comparison of platinum-based neoadjuvant chemotherapy and primary debulking surgery in patients with advanced ovarian cancer
ناشر 7
آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ بلی
عنوان نشریه (خارج از لیست فوق) Journal of obstetrics and gynaecology of India
نوع مقاله Original Article
نحوه ایندکس شدن مقاله ایندکس شده سطح دو – PubMed
آدرس لینک مقاله/ همایش در شبکه اینترنت

خلاصه مقاله
hide/show

Purpose Ovarian cancer is the sixth common cancer in women in developed countries. In severe cases, the optimal debulking is necessary. In order to increase optimal debulking and reduce preoperative complications, neoadjuvant chemotherapy followed by debulking surgery, and then chemotherapy again is introduced as substitute for primary surgery. In this study, we aim to evaluate perioperative outcome after neoadjuvant chemotherapy with carboplatin/paclyaxol in comparison with primary cytoreduction in patients with advanced ovarian cancer. Methods In this prospective study, 60 patients with advanced ovarian cancer due to the disease severity were assigned into neoadjuvant chemotherapy (n = 30) or control (n = 30) groups. In neoadjuvant chemotherapy group, patients received three cycles of carboplatin (5–6 area under the curve) and paclitaxel (175 mg/m2) preoperatively followed by interval surgery. The control group received primary surgery plus adjuvant chemotherapy. Preoperative outcome was compared between groups. Results Neoadjuvant group had significantly lower mean levels of CA 125 (p = 0.01) and less severe bleeding (p = 0.03) than control group. There was no significant difference between surgery time, preoperative complications, residual mass less than 1 cm, and hospital stay between groups. There was no mortality during the study. Conclusion Neoadjuvant chemotherapy caused less severe bleeding, but has no effect in decreasing complications after surgery; however, neoadjuvant chemotherapy followed by interval debulking surgery was not superior to primary debulking surgery followed by chemotherapy as a treatment option for patients with advanced ovarian carcinoma in this study.

نویسندگان
hide/show

نویسنده نفر چندم مقاله
منیژه سیاح ملیاول
شهریار هاشم زادهسوم
علی اصفهانیچهارم
الهه اولاد صاحب مدارکپنجم
مهری جعفری شبیریششم
پروین مصطفی قره باغیهفتم
رامین آژوغهشتم

لینک دانلود مقاله
hide/show

نام فایل تاریخ درج فایل اندازه فایل دانلود
2013 platinium.pdf1399/01/23383885دانلود